NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
12/23/2025
Back to search
Official data from USPTO
JP JAZZ PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
12/23/2025
Classification
Registered
Trademark type
Combined
Nice classes
36
Filing date
12/10/2018
Registration date
07/23/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/01/2025
Last transaction
12/23/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
04/21/2006
First use in commerce
04/21/2006
Drawing code
3
Owner type
03
Owner location
Palo Alto, CA
Examiner
LEE,JEANIE H
Current location
Historical data usage
Mark description
The mark consists of "JAZZ PHARMACEUTICALS" positioned to the right of a circular logo with a stylized depiction of the letters "JP" which vertically splits the circle.
Holders and representatives
Holders
Jazz Pharmaceuticals, Inc.
Representatives
Michael Olsen Winthrop & Weinstine, P.A.
Technical classification
Nice Classes
Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Providing information in insurance matters; insurance consultation; health care insurance consultation in the nature of providing assistance to others in obtaining insurance reimbursement of medical expenses for pharmaceuticals
Publications
History of USPTO decisions and trademark events.
34 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/01/2025
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/01/2025
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
12/01/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/18/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/12/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/11/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/11/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/11/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/11/2025
ES7R
TEAS SECTION 7 REQUEST RECEIVED
07/29/2025
E815
TEAS SECTION 8 & 15 RECEIVED
07/22/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/23/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/26/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/15/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/15/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2019
PUBO
PUBLISHED FOR OPPOSITION
05/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/17/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/01/2019
ALIE
ASSIGNED TO LIE
03/31/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/25/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/25/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/13/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
03/11/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/11/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
03/11/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/11/2019
DOCK
ASSIGNED TO EXAMINER
03/07/2019
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/02/2019
NWAP
NEW APPLICATION ENTERED
12/13/2018
Continuous trademark protection
Get notified about every new filing that threatens JP JAZZ PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.